Skip to main content
Premium Trial:

Request an Annual Quote

... As Invitrogen Inks Screening-Services Deal With Plexxikon

NEW YORK, April 7 (GenomeWeb News) - Invitrogen yesterday announced a kinase-screening services deal with Berkeley, Calif.- based Plexxikon.


Plexxikon is combining X-ray crystallography, molecular modeling, and chemistry to design compounds against certain disease targets.


Financial details were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.